Programme no. 407-SY
Equitable care in diabetes: High risk patients: How to spot them and the effect of treating them
Per Erik Wändell*1, Niels de Fine Olivarius2, Anh Thi Tranh3
1Karolinska Institutet,Huddinge,Sweden, 2University of Copenhagen,Copenhagen,Denmark, 3University of Oslo,Oslo,Norway
* = Presenting author
Objectives: To present results from the treatment of subgroups of the population who are at increased risk of acquiring type 2 diabetes, and who are at increased risk of diabetic complications and death after the diagnosis of diabetes.
Background: Subjects with low socio-economic status, psychiatric comorbidity, cancer comorbidity, multimorbidity, and male sex as well as immigrants from non-Western/non-European countries, are at increased risk of both diabetes and increased risk of complications after diagnosis. Can the general practitioner spot these patients and increase the quality of their care?
Content: Diabetes educational programs for non-Western immigrants as well as campaigns in the society to increase knowledge about diabetes in these populations will be discussed. Structured treatment programs in primary care for dealing with patients with type 2 diabetes will be presented and discussed. Focus will be on groups at high risk of diabetic complications and the effect of increasing the quality of the treatment of these patients: Patients with psychiatric disease, cancer, multimorbidity, male sex and multiple outcomes. The general practitioners’ existing knowledge of patients’ life circumstances, motivation and effort in diabetes management should be included in treatment strategies to prevent diabetic complications.
Method: We will present data from clinical and registry-based studies from primary care.
Other considerations: In the daily clinical work in general practice it is important to identify subjects at high risk of type 2 diabetes as well as patients at high risk of diabetic complications and early death. It is equally important to focus on improving the treatment quality for these high-risk groups.